img

Global Tuberculosis (TB) Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tuberculosis (TB) Treatment Market Insights, Forecast to 2034

If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
Market Analysis and InsightsGlobal Tuberculosis (TB) Treatment Market
Global Tuberculosis (TB) Treatment market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Tuberculosis (TB) Treatment industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Tuberculosis (TB) Treatment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Tuberculosis (TB) Treatment market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi
Segment by Type
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Segment by Application


Active TB
Latent TB
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Tuberculosis (TB) Treatment introduction, etc. Tuberculosis (TB) Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Tuberculosis (TB) Treatment
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Isoniazid
1.2.3 Rifampin (Rifadin, Rimactane)
1.2.4 Ethambutol (Myambutol)
1.2.5 Pyrazinamide
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Active TB
1.3.3 Latent TB
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Treatment Market Perspective (2018-2033)
2.2 Global Tuberculosis (TB) Treatment Growth Trends by Region
2.2.1 Tuberculosis (TB) Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tuberculosis (TB) Treatment Historic Market Size by Region (2018-2023)
2.2.3 Tuberculosis (TB) Treatment Forecasted Market Size by Region (2024-2033)
2.3 Tuberculosis (TB) Treatment Market Dynamics
2.3.1 Tuberculosis (TB) Treatment Industry Trends
2.3.2 Tuberculosis (TB) Treatment Market Drivers
2.3.3 Tuberculosis (TB) Treatment Market Challenges
2.3.4 Tuberculosis (TB) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tuberculosis (TB) Treatment by Players
3.1.1 Global Tuberculosis (TB) Treatment Revenue by Players (2018-2023)
3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tuberculosis (TB) Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Tuberculosis (TB) Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Treatment Revenue in 2022
3.5 Global Key Players of Tuberculosis (TB) Treatment Head office and Area Served
3.6 Global Key Players of Tuberculosis (TB) Treatment, Product and Application
3.7 Global Key Players of Tuberculosis (TB) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Treatment Breakdown Data by Type
4.1 Global Tuberculosis (TB) Treatment Historic Market Size by Type (2018-2023)
4.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2024-2033)
5 Tuberculosis (TB) Treatment Breakdown Data by Application
5.1 Global Tuberculosis (TB) Treatment Historic Market Size by Application (2018-2023)
5.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tuberculosis (TB) Treatment Market Size (2018-2033)
6.2 North America Tuberculosis (TB) Treatment Market Size by Type
6.2.1 North America Tuberculosis (TB) Treatment Market Size by Type (2018-2023)
6.2.2 North America Tuberculosis (TB) Treatment Market Size by Type (2024-2033)
6.2.3 North America Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
6.3 North America Tuberculosis (TB) Treatment Market Size by Application
6.3.1 North America Tuberculosis (TB) Treatment Market Size by Application (2018-2023)
6.3.2 North America Tuberculosis (TB) Treatment Market Size by Application (2024-2033)
6.3.3 North America Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
6.4 North America Tuberculosis (TB) Treatment Market Size by Country
6.4.1 North America Tuberculosis (TB) Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Tuberculosis (TB) Treatment Market Size by Country (2018-2023)
6.4.3 North America Tuberculosis (TB) Treatment Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Treatment Market Size (2018-2033)
7.2 Europe Tuberculosis (TB) Treatment Market Size by Type
7.2.1 Europe Tuberculosis (TB) Treatment Market Size by Type (2018-2023)
7.2.2 Europe Tuberculosis (TB) Treatment Market Size by Type (2024-2033)
7.2.3 Europe Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
7.3 Europe Tuberculosis (TB) Treatment Market Size by Application
7.3.1 Europe Tuberculosis (TB) Treatment Market Size by Application (2018-2023)
7.3.2 Europe Tuberculosis (TB) Treatment Market Size by Application (2024-2033)
7.3.3 Europe Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
7.4 Europe Tuberculosis (TB) Treatment Market Size by Country
7.4.1 Europe Tuberculosis (TB) Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Tuberculosis (TB) Treatment Market Size by Country (2018-2023)
7.4.3 Europe Tuberculosis (TB) Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tuberculosis (TB) Treatment Market Size (2018-2033)
8.2 China Tuberculosis (TB) Treatment Market Size by Type
8.2.1 China Tuberculosis (TB) Treatment Market Size by Type (2018-2023)
8.2.2 China Tuberculosis (TB) Treatment Market Size by Type (2024-2033)
8.2.3 China Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
8.3 China Tuberculosis (TB) Treatment Market Size by Application
8.3.1 China Tuberculosis (TB) Treatment Market Size by Application (2018-2023)
8.3.2 China Tuberculosis (TB) Treatment Market Size by Application (2024-2033)
8.3.3 China Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Tuberculosis (TB) Treatment Market Size (2018-2033)
9.2 Asia Tuberculosis (TB) Treatment Market Size by Type
9.2.1 Asia Tuberculosis (TB) Treatment Market Size by Type (2018-2023)
9.2.2 Asia Tuberculosis (TB) Treatment Market Size by Type (2024-2033)
9.2.3 Asia Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
9.3 Asia Tuberculosis (TB) Treatment Market Size by Application
9.3.1 Asia Tuberculosis (TB) Treatment Market Size by Application (2018-2023)
9.3.2 Asia Tuberculosis (TB) Treatment Market Size by Application (2024-2033)
9.3.3 Asia Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
9.4 Asia Tuberculosis (TB) Treatment Market Size by Region
9.4.1 Asia Tuberculosis (TB) Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Tuberculosis (TB) Treatment Market Size by Region (2018-2023)
9.4.3 Asia Tuberculosis (TB) Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.1.5 Johnson & Johnson Recent Developments
11.2 Otsuka Pharmaceutical Co., Ltd
11.2.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.2.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Introduction
11.2.4 Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.2.5 Otsuka Pharmaceutical Co., Ltd Recent Developments
11.3 Macleods Pharmaceutical Ltd
11.3.1 Macleods Pharmaceutical Ltd Company Details
11.3.2 Macleods Pharmaceutical Ltd Business Overview
11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Introduction
11.3.4 Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.3.5 Macleods Pharmaceutical Ltd Recent Developments
11.4 Dong-A ST Co., Ltd
11.4.1 Dong-A ST Co., Ltd Company Details
11.4.2 Dong-A ST Co., Ltd Business Overview
11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Introduction
11.4.4 Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.4.5 Dong-A ST Co., Ltd Recent Developments
11.5 Lupin Ltd
11.5.1 Lupin Ltd Company Details
11.5.2 Lupin Ltd Business Overview
11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Introduction
11.5.4 Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.5.5 Lupin Ltd Recent Developments
11.6 Janssen Products, LP
11.6.1 Janssen Products, LP Company Details
11.6.2 Janssen Products, LP Business Overview
11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Introduction
11.6.4 Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.6.5 Janssen Products, LP Recent Developments
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Tuberculosis (TB) Treatment Introduction
11.7.4 Mylan Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.7.5 Mylan Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tuberculosis (TB) Treatment Introduction
11.8.4 Sanofi Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.8.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Isoniazid
Table 3. Key Players of Rifampin (Rifadin, Rimactane)
Table 4. Key Players of Ethambutol (Myambutol)
Table 5. Key Players of Pyrazinamide
Table 6. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Tuberculosis (TB) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Tuberculosis (TB) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Tuberculosis (TB) Treatment Market Share by Region (2018-2023)
Table 10. Global Tuberculosis (TB) Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Tuberculosis (TB) Treatment Market Share by Region (2024-2033)
Table 12. Tuberculosis (TB) Treatment Market Trends
Table 13. Tuberculosis (TB) Treatment Market Drivers
Table 14. Tuberculosis (TB) Treatment Market Challenges
Table 15. Tuberculosis (TB) Treatment Market Restraints
Table 16. Global Tuberculosis (TB) Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Tuberculosis (TB) Treatment Revenue Share by Players (2018-2023)
Table 18. Global Top Tuberculosis (TB) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2022)
Table 19. Global Tuberculosis (TB) Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Tuberculosis (TB) Treatment, Headquarters and Area Served
Table 22. Global Key Players of Tuberculosis (TB) Treatment, Product and Application
Table 23. Global Key Players of Tuberculosis (TB) Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Tuberculosis (TB) Treatment Revenue Share by Application (2018-2023)
Table 31. Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Tuberculosis (TB) Treatment Revenue Share by Application (2024-2033)
Table 33. North America Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Tuberculosis (TB) Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Tuberculosis (TB) Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Tuberculosis (TB) Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Tuberculosis (TB) Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Tuberculosis (TB) Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Tuberculosis (TB) Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Tuberculosis (TB) Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Tuberculosis (TB) Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Tuberculosis (TB) Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Tuberculosis (TB) Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Tuberculosis (TB) Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Tuberculosis (TB) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Tuberculosis (TB) Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 65. Johnson & Johnson Company Details
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Tuberculosis (TB) Treatment Product
Table 68. Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 69. Johnson & Johnson Recent Developments
Table 70. Otsuka Pharmaceutical Co., Ltd Company Details
Table 71. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 72. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product
Table 73. Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 74. Otsuka Pharmaceutical Co., Ltd Recent Developments
Table 75. Macleods Pharmaceutical Ltd Company Details
Table 76. Macleods Pharmaceutical Ltd Business Overview
Table 77. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product
Table 78. Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 79. Macleods Pharmaceutical Ltd Recent Developments
Table 80. Dong-A ST Co., Ltd Company Details
Table 81. Dong-A ST Co., Ltd Business Overview
Table 82. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product
Table 83. Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 84. Dong-A ST Co., Ltd Recent Developments
Table 85. Lupin Ltd Company Details
Table 86. Lupin Ltd Business Overview
Table 87. Lupin Ltd Tuberculosis (TB) Treatment Product
Table 88. Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 89. Lupin Ltd Recent Developments
Table 90. Janssen Products, LP Company Details
Table 91. Janssen Products, LP Business Overview
Table 92. Janssen Products, LP Tuberculosis (TB) Treatment Product
Table 93. Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 94. Janssen Products, LP Recent Developments
Table 95. Mylan Company Details
Table 96. Mylan Business Overview
Table 97. Mylan Tuberculosis (TB) Treatment Product
Table 98. Mylan Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 99. Mylan Recent Developments
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Tuberculosis (TB) Treatment Product
Table 103. Sanofi Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 104. Sanofi Recent Developments
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Tuberculosis (TB) Treatment Market Share by Type: 2022 VS 2033
Figure 3. Isoniazid Features
Figure 4. Rifampin (Rifadin, Rimactane) Features
Figure 5. Ethambutol (Myambutol) Features
Figure 6. Pyrazinamide Features
Figure 7. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Tuberculosis (TB) Treatment Market Share by Application: 2022 VS 2033
Figure 9. Active TB Case Studies
Figure 10. Latent TB Case Studies
Figure 11. Tuberculosis (TB) Treatment Report Years Considered
Figure 12. Global Tuberculosis (TB) Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Tuberculosis (TB) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Tuberculosis (TB) Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Tuberculosis (TB) Treatment Market Share by Players in 2022
Figure 16. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Treatment Revenue in 2022
Figure 18. North America Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
Figure 20. North America Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
Figure 21. North America Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 22. United States Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Tuberculosis (TB) Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
Figure 26. Europe Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
Figure 27. Europe Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 28. Germany Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Tuberculosis (TB) Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
Figure 36. China Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
Figure 37. Asia Tuberculosis (TB) Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
Figure 39. Asia Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
Figure 40. Asia Tuberculosis (TB) Treatment Market Share by Region (2018-2033)
Figure 41. Japan Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 51. Brazil Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Johnson & Johnson Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 58. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 59. Macleods Pharmaceutical Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 60. Dong-A ST Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 61. Lupin Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 62. Janssen Products, LP Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 63. Mylan Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 64. Sanofi Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries